Feed TGTX
TG
TG Therapeutics
TGTX · NASDAQ
$49.28 +0.98% (+$0.48)
1M -8.67%
Market Cap $7.5B
P/E Ratio 16.87x
Div. Yield -
ROE 135.59%
Bulios Fair Price
$47.83
2.9% downside
Current Price
$49.28
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TGTX is currently trading close to its fair value. How does it work?
Piotroski F-Score Moderate
4/9Valuation
32 /100
Expensive P/S 12.24x
P/E 16.87x
P/B 11.64x
Growth
100 /100
Growing Book val. growth 122.81%
Rev. growth 504.86%
FCF growth N/A
Profitability
65 /100
Moderate Op. margin 20.01%
Gross margin 83.66%
FCF margin 4.05%
Quality
92 /100
Excellent ROA 42.06%
ROIC 56.40%
Asset turnover 0.58x
Debt
81 /100
Low Int. coverage 5.02x
Debt/Equity 0.40x
Net debt/EBITDA 1.35x
Stability
13 /100
Unstable EPS volatility 956.11%
Beta 1.67x
Profitable years 3
Ask StockBot about TGTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael S. Weiss
Employees
399
Headquarters
Morrisville
Upcoming events
02 NOV
Earnings
Upcoming earnings report